A pioneering research and development (R&D) company at the forefront of biotechnology innovation. With a passion for driving advancements in the life sciences, our multidisciplinary team of experts combine cutting-edge knowledge with unrivalled consultancy services. At iNatural Ltd, we specialise in the production and characterisation of biosynthetic polymeric materials for biomedical applications. Our scientific team also specialise in gut Health and Biomedical Research, revolutionising the way we understand and harness the potential of the human microbiome. Through our collaborative approach and dedication to scientific excellence, we strive to shape a healthier and more sustainable future for all.
• Natural cellulose-based biosynthetic polymers have emerged as a remarkable innovation with profound potential for transformative medical applications. At iNatural Ltd, we are passionately dedicated to exploring the vast capabilities of these biomaterials and harnessing their unique properties to revolutionise the field of medicine.
• Plant cellulose, a naturally abundant and renewable biopolymer is commonly used in wound dressings. We specialise in biosynthetic ultra-pure cellulose produced by various bacterial strains, serving as the cornerstone of our research endeavours.
• Through advances in biotechnology and material science, at iNatural Ltd we aim to unlock the full therapeutic potential of cellulose-based biosynthetic polymers, paving the way for a new era of regenerative medicine, drug delivery systems, and biomedical devices.
In the evolving scientific advancements, nanotechnology has attracted a wide research interest in the biomedical field. At the heart of this trailblazing endeavour lies a firm commitment to an environmentally friendly approach. Through cutting-edge research and sustainable practices, our scientists and innovators are revolutionising the way nanoparticles are synthesised, ensuring minimal ecological impact. These nanoparticles, produced using natural products have unique properties, advocating their potential applications in the biomedical sector. In this exploration of nanoparticle technology, we delve into the ingenious amalgamation of environmentally conscious production techniques and their extraordinary applications in the biomedical field, paving the way for a brighter, greener, and healthier future.
Multiple drug resistance has encouraged scientist to look for antibiotic alternatives for controlling infections. Mother nature has provided many natural products with antimicrobial, healing and remedial properties for biomedical applications. At iNatural Ltd, our scientists specialise in selecting these natural potent materials, converting the active compounds into suitable formulations, using appropriate techniques, and evaluating their biological compatibility, to enhance their translational biomedical application potential. At iNatural Ltd., our research team specialise in using natural products for wound health and for gut health, as prebiotics. We are actively involved in research and development in these biomedical sectors.
• In the realm of nutrition and digestive health, prebiotics have gained significant attention for their beneficial impact on the gut microbiome. Various plant-based sources serve as a nourishing substrate for beneficial gut bacteria, fostering their growth and activity and promote overall well-being.
• Psyllium husk, derived from the seeds of the Plantago ovata plant, is rich in soluble fibre and renowned for its capacity to enhance bowel movements and alleviate constipation.
• Inulin, a naturally occurring carbohydrate found in various plant sources, is used to enrich food with natural fibres. Together, these prebiotic powerhouses offer a compelling synergy that can positively influence our digestive health and pave the way for a more balanced and vibrant lifestyle.
iNatural Ltd is at the forefront of innovative research and development in biosynthetic polymers, gut health, food supplements, and nanotechnology. With a team of accomplished scientists and clinicians, we bring forth a groundbreaking idea aimed at making a meaningful contribution to a brighter future. Sustainability in biomedical research involves integrating environmentally conscious practices and responsible resource management to advance scientific discoveries while minimising the impact on the natural world. At iNatural Ltd., environmental sustainability lies at the heart of everything we do. We are driven by a deep-rooted commitment to an environment-friendly approach that guides our innovation and decision-making processes.
Dr Abhishek Gupta, our Chief Scientific Officer (CSO) is an experienced researcher and educator with international track record in the production and characterisation of biosynthetic polymers for potential biomedical applications. Dr Gupta has many peer-reviewed international publications in his account. Along with nanotechnology, Dr Gupta specialise in natural products with biomedical remediation applications. He has presented his research at several national and international conferences and won many awards. He has research collaborations in several countries. Dr Abhishek Gupta’s passion for scientific discovery, to help treatments for vital areas of medicine, is globally recognised, including the regional Express and Star newspaper. He was presented with the highest diasporic award, Hind Rattan Award by the NRI Welfare Society in 2021 and the prestigious International Education Award during the Global Education Summit and Conference at the University of Oxford. Dr Gupta has expertise in nanotechnology with intended biomedical applications. His published research work has been placed in the top 1% of the academic field of Biology & Biochemistry based on a highly cited threshold for the filed and publication year.
In the world of entrepreneurship and scientific exploration, age knows no boundaries, and innovation knows no age. Krish's fascination with the biomedical realm began when he was just 6 years old. During his early year of primary school, he confidently presented on the cardiovascular system, digestive system, and skeletal system. Fast forward to the present, at 16 years old, Krish has taken his curiosity to a whole new level by establishing iNatural Ltd. Krish Gupta is a visionary prodigy who defies conventional norms and has embarked on an extraordinary journey to revolutionise the landscape of gut health, biotechnology, and research. As the Director and Founder of iNatural Ltd, Krish brings a fresh perspective and boundless curiosity to the realm of scientific discovery. With an insatiable thirst for knowledge and an unwavering passion for making a positive impact, Krish has fearlessly taken the helm, determined to pave the way for groundbreaking advancements in gut health and biotechnology.
At iNatural Ltd., collaboration is at the heart of our commitment to innovation and excellence. We are proud to partner with esteemed institutions and organisations that share our dedication to advancing healthcare solutions. Our partnership with the University of Wolverhampton brings a wealth of academic knowledge and research capabilities to our projects. Our association with international partners like the Punjabi University, India enriches our global perspective and cultural diversity. Together, these collaborations empower us to contribute to the well-being of individuals worldwide.
Wound care's significance has surged within the healthcare sector, primarily driven by the rising prevalence of chronic wounds in vulnerable populations such as the elderly, immunocompromised individuals, and obese patients. Additionally, the global diabetic incidence, as reported by the World Health Organization, has climbed from 108 million in 1980 to 422 million in 2014, further accentuating the need for advanced wound treatment. The management of wound care presents a significant challenge, evident in the 2022 global market estimate exceeding $20.8 billion, and it is expected to rise to approximately $27.2 billion by 2027.
Numerous adults are uninformed about their gut health The adult human gut houses trillions of microorganisms, encompassing over 1,000 species, forming a symbiotic relationship with the host. This intestinal microflora plays a crucial role in digestion, nutrient absorption, immune system regulation, and Wound Care. Dysbiosis, an imbalance in this ecosystem can result from loss of beneficial organisms or excessive growth of potentially harmful organisms. It is associated with diseases like Inflammatory Bowel Disease, obesity, Type 1 diabetes, and colorectal cancer in humans. Elements such as insufficient sleep, heightened stress levels, antibiotic use, and an unhealthy diet can influence the gut health. Should you observe indicators of compromised gut health, modifying lifestyle factors could enhance your gut microbiome and contribute to your overall well-being. Eating healthy diet with a good balance of prebiotics and probiotics can help balance gut microflora. In 2021, the global prebiotics market attained a worth of $6.05 billion, and it is anticipated to demonstrate a compound annual growth rate (CAGR) of 14.9% from 2022 to 2030. Concurrently, the probiotics market is experiencing rapid expansion, with an expected CAGR of 8.1% between 2022 and 2027.
Gupta, A. et al., 2020. Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose Based Hydrogels for Wound Dressing Applications. BioMacromolecules, 21(5), pp. 1802–1811 Want to know more? Click here
Gupta, A. et al., 2020. Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose Based Hydrogels for Wound Dressing Applications. BioMacromolecules, 21(5), pp. 1802–1811
Gupta, A. et al., 2019. Production and characterisation of bacterial cellulose hydrogels loaded with curcumin encapsulated in Cyclodextrins as wound dressings. European Polymer Journal, 118, pp. 437-450 Want to know more? Click here
Gupta, A. et al., 2019. Production and characterisation of bacterial cellulose hydrogels loaded with curcumin encapsulated in Cyclodextrins as wound dressings. European Polymer Journal, 118, pp. 437-450
Gupta, A. et al., 2019. The production and application of hydrogels for wound management- A review. European Polymer Journal, 111, pp.134-151. Want to know more? Click here
Gupta, A. et al., 2019. The production and application of hydrogels for wound management- A review. European Polymer Journal, 111, pp.134-151.
Gupta, A. et al., 2017. Physicochemical characterisation of biosynthetic bacterial cellulose as a potential wound dressing material. British Journal of Pharmacy, 2(2), pp. S37-38. Want to know more? Click here
Gupta, A. et al., 2017. Physicochemical characterisation of biosynthetic bacterial cellulose as a potential wound dressing material. British Journal of Pharmacy, 2(2), pp. S37-38.
Gupta, A. et al., 2016. Characterisation and in vitro antimicrobial activity of biosynthetic silver-loaded bacterial cellulose hydrogels. Journal of Microencapsulation, 33(8), pp. 725-734. DOI: Want to know more? Click here
Gupta, A. et al., 2016. Characterisation and in vitro antimicrobial activity of biosynthetic silver-loaded bacterial cellulose hydrogels. Journal of Microencapsulation, 33(8), pp. 725-734. DOI:
Chopra D, et al., 2008. Use of Liposomal Drugs in the treatment of Rheumatoid Arthritis. Current Rheumatology Reviews 2008; 4(1), pp. 63-70. DOI: Want to know more? Click here
Chopra D, et al., 2008. Use of Liposomal Drugs in the treatment of Rheumatoid Arthritis. Current Rheumatology Reviews 2008; 4(1), pp. 63-70. DOI:
Chopra D, et al., 2008. Thermal and Isothermal Methods in Development of Sustained Release Dosage Forms of Ketorolac Tromethamine. E-J.Chem; 5(2), pp.316-322. Want to know more? Click here
Chopra D, et al., 2008. Thermal and Isothermal Methods in Development of Sustained Release Dosage Forms of Ketorolac Tromethamine. E-J.Chem; 5(2), pp.316-322.
Chopra, D. et al., 2008. Brain Permeable Nanoparticles. Recent Patents on CNS Drug Discovery (ISSN: 1574-8898) 2008; 3(3), pp. 216-225.